109 related articles for article (PubMed ID: 3265704)
1. Silybin inhibition of human T-lymphocyte activation.
Meroni PL; Barcellini W; Borghi MO; Vismara A; Ferraro G; Ciani D; Zanussi C
Int J Tissue React; 1988; 10(3):177-81. PubMed ID: 3265704
[TBL] [Abstract][Full Text] [Related]
2. Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high doses.
Johnson VJ; He Q; Osuchowski MF; Sharma RP
Planta Med; 2003 Jan; 69(1):44-9. PubMed ID: 12567278
[TBL] [Abstract][Full Text] [Related]
3. [Stimulation of RNA synthesis in rat liver and isolated hepatocytes by silybin, an antihepatotoxic agent from Silybum marianum L. Gaertn (author's transl)].
Sonnenbichler J; Mattersberger J; Rosen H
Hoppe Seylers Z Physiol Chem; 1976 Aug; 357(8):1171-80. PubMed ID: 976944
[TBL] [Abstract][Full Text] [Related]
4. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
5. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
[TBL] [Abstract][Full Text] [Related]
7. The influence of silybin from Silybum marianum (L.) Gaertn. on in vitro phosphatidyl choline biosynthesis in rat livers.
Schriewer H; Weinhold F
Arzneimittelforschung; 1979; 29(5):791-2. PubMed ID: 582978
[TBL] [Abstract][Full Text] [Related]
8. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
[TBL] [Abstract][Full Text] [Related]
10. [Anti-phalloidine activity of the silymarins silybine and disilybine].
Vogel VG; Trost W
Arzneimittelforschung; 1975 Mar; 25(3):392-3. PubMed ID: 1174039
[TBL] [Abstract][Full Text] [Related]
11. Effects of two bioflavonoids on certain cellular immune reactions in vitro.
Deák G; Müzes G; Láng I; Nékám K; González-Cabello R; Gergely P; Fehér J
Acta Physiol Hung; 1990; 76(2):113-21. PubMed ID: 2082690
[TBL] [Abstract][Full Text] [Related]
12. In vitro response of bovine thoracic duct lymphocyte to phytohaemagglutinin following adult thymectomy.
Sharbaugh RJ; Ainsworth SK; Fitts CT
Clin Exp Immunol; 1976 Aug; 25(2):342-6. PubMed ID: 1085239
[TBL] [Abstract][Full Text] [Related]
13. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline inhibits adhesion and activation of human T lymphocytes.
González-Amaro R; Portales-Pérez D; Baranda L; Redondo JM; Martínez-Martínez S; Yáñez-Mó M; García-Vicuña R; Cabañas C; Sánchez-Madrid F
J Immunol; 1998 Jul; 161(1):65-72. PubMed ID: 9647208
[TBL] [Abstract][Full Text] [Related]
15. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
18. Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.
Stevenson HC; Fauci AS
Immunology; 1980 Mar; 39(3):391-7. PubMed ID: 7002766
[TBL] [Abstract][Full Text] [Related]
19. Two structurally identical mannose-specific jacalin-related lectins display different effects on human T lymphocyte activation and cell death.
Benoist H; Culerrier R; Poiroux G; Ségui B; Jauneau A; Van Damme EJ; Peumans WJ; Barre A; Rougé P
J Leukoc Biol; 2009 Jul; 86(1):103-14. PubMed ID: 19401384
[TBL] [Abstract][Full Text] [Related]
20. Effect of copper on activation of human T cells.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):147-52. PubMed ID: 3261746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
